Hip and Knee Replacement in the HIV positive patient by Anand, ER et al.
Malawi Medical Journal; 24(1): 14-16 March 2012 Case Study: HIV test misdiagnosis 14
Hip and Knee Replacement in the HIV positive patient 
   Abstract
Arthroplasty is used to relieve pain associated with degenerative or 
inflammatory joint disease, some post-traumatic joint problems, and 
avascular necrosis. Avascular necrosis, inflammatory and post-traumatic 
problems are seen on a regular basis in areas of  high HIV seroprevalence. 
Degenerative arthritis is rare in younger HIV patients, however. Historically 
the only group of  HIV patients in which arthroplasty has been common 
is that which received contaminated factor VIII transfusions in the 1980’s. 
Haemophiliacs get a haemophilic arthropathy from repeated bleeds into 
joints and so is an additional complication.
Much of  the previous literature on this topic has focused on haemophiliac 
patients. This review examines the success of  arthroplasty in HIV positive 
patients, with an emphasis on non-haemophiliac patients. We conclude 
that arthroplasty can be a safe procedure for HIV positive individuals if  the 
surgery is carried out in good conditions, and early results are encouraging.
Introduction
Arthroplasty, the process of  joint replacement, is used to 
relieve pain associated with degenerative or inflammatory 
joint disease, some post-traumatic joint problems, and 
avascular necrosis. Whilst degenerative arthritis may be 
relatively rare in HIV patients who are predominantly of  
a younger age group, avascular necrosis, inflammatory and 
post-traumatic problems are seen on a regular basis in 
areas of  high HIV seroprevalence.  The appropriateness 
or otherwise of  arthroplasty in such patients is therefore a 
pertinent question. 
There are a number of  concerns regarding outcome of  
arthroplasty surgery in HIV patients including anaesthetic 
issues, early and late sepsis, and aseptic loosening in cases 
of  long-term survivors.  Additionally the implantation of  
precisely engineered joints is an expensive procedure requiring 
advanced technical skills and aseptic operating environment 
not commonly available in developing countries, where HIV 
is most common.  The only group of  HIV patients in which 
arthroplasty has been common are those with haemophilia 
who received contaminated factor VIII transfusions in the 
early 1980’s. Such patients reside in developed countries 
where arthroplasty is freely available.  As a result there is far 
more literature on arthroplasty in haemophiliac HIV patients 
than there is on non-haemophiliac patients. 
Most developing countries now have at least one centre 
undertaking regular lower limb arthroplasty. Patients with 
HIV disease now commonly access antiretroviral therapy, 
and have an extended life expectancy. As a result of  these 
factors, such patients now regularly present to be considered 
for arthroplasty, and clinicians need to appreciate the issues 
and evidence to date. This review aims to focus on these 
issues.
HIV positive patients suffer progressively deteriorating 
immunity, as their CD4 count falls, and are consequently 
prone to opportunistic infections.1Studies have shown that 
HIV positive haemophiliacs tend to have a higher risk of  
infection after joint replacement.2 The plight of  HIV positive 
non-haemophiliacs on the other hand is relatively unknown. 
There have been retrospective and inconsistent reports 
on HIV positive patients undergoing surgery, but in this 
review we will focus on the existing evidence for the use of  
arthroplasty in HIV positive patients, with a particular focus 
on non-haemophiliacs.
Review of literature
Arthroplasty in HIV positive haemophiliacs
Hicks et al showed in a multicentre, retrospective study3 there 
was an increased risk of  sepsis after joint replacement in 
HIV-positive haemophiliacs. This involved 102 arthroplasties 
in 73 HIV-positive patients who were available for detailed 
study. There were 74 replacements of  the knee (72.5%), 27 
of  the hip (26.5%) and one of  the elbow (1%). Of  these, 
91 were primary and 11 were revision procedures.  The rate 
of  deep sepsis was 18.7% (17/91) after primary procedures 
and 36.3% (4/11) after revision procedures.  A number of  
other studies support the finding of  an increased sepsis risk 
in HIV-positive haemophiliacs. 
Wiedel et al4 in 1989 reported a higher risk of  acute infections 
in the haemophiliac HIV positive patients amongst the 76 
patients undergoing a total of  97 Total knee arthroplasties.
Norian et al5 reported 53 total knee arthroplasties that were 
carried out between 1976 and 1998 to treat haemophilic 
arthropathy in 38 patients (29 were HIV positive), and results 
confirmed that TKA has a high risk of  failure associated 
with infection (frequently Staphylococcus epidermis)
Gregg Smith and Pattinson6 recorded cases of  Septic 
arthritis in haemophilia patients: 6 patients were treated 
for haemophilic haemarthrosis over a period of  two years. 
Four of  the six patients were seropositive for anti-HIV, 
and the authors of  the study reported that septic arthritis 
can develop in subjects who are in otherwise good health, 
without obvious symptoms of  HIV infection. They have 
suggested that the high risk of  secondary infection is reason 
to perform joint replacement in haemophiliac patients with 
special care and in a very carefully selected group.
Ragni et al7 reviewed 66 haemophilic patients undergoing 
74 orthopaedic procedures, each of  whom had CD4 counts 
of  less than 200 cells, and found that the post operative 
infection rate for arthroplasty appears to be increased 10-
fold compared with other procedures.
Thomason et al8 published results of  23 total knee 
arthroplasties in 15 haemophiliac patients, and found 2 early 
and 2 late deep infections, all occurring in HIV seropositive 
patients.
Operating on haemophiliacs presents particular problems 
as we pointed out2 previously and so the reported success 
rates and methods of  arthroplasty on these patients cannot 
be necessarily translated to non-haemophiliac patients. 
Haemophiliacs are especially prone to bleeding around 
their joints and may suffer bacteraemia due to regular factor 
VIII transfusions2.  HIV-negative haemophiliacs suffer an 
increased risk of  infection following arthroplasty4,9, and 
so the increased risk of  infection found in HIV-positive 
haemophiliac patients may be due to their haemophilia rather 
than HIV. However, the literature is generally concurrent 
with the view that total hip replacement is of  value in HIV 
positive haemophilic individuals, because of  the improved 
quality of  life such an operation can produce.
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Arthroplasty in HIV-positive non-haemophiliacs
Despite arthroplasty in non-haemophiliac HIV-positive 
patients being previously rare there are reported incidences 
of  it.  A study by Brijlall1 found no incidences of  infection 
at a six year follow-up despite 3 out of  the 14 patients having 
a CD4 count of  less than 200 cells/mm3. The mean pre-
lymphocyte analysis of  these patients showed: TLC – 2.24 
mm3, CD4 – 425/mm3, CD8 – 873/mm3, CD4/CD8 – 
0.52. Mean post-lymphocyte analysis at 6 years: TLC – 1.98, 
CD4 – 350 mm3, CD8 – 724 mm3. 3 patients declined to 
an average of  113.6/mm3 and are consequently receiving 
HAART (Highly Active Antiretroviral Therapy - zidovudine, 
didanosine, lopanivir).
A National Joint Registry study by Lubega et al10 at this 
institution found no difference in early infection between 
the 14 patients (18 hips) who were HIV-positive and the 28 
patients who were HIV-negative.  2 We also reported our 
early experience with 4 total hip replacements in two patients 
with bilateral avascular necrosis, one of  whom had a CD4 
count of  less than 100 cells/mm3, but no sepsis was seen in 
a mean 2-year follow up period. 
 Patients with avascular necrosis on the other hand have 
experienced a higher incidence of  aseptic loosening. Both 
aseptic loosening and osteonecrosis are independent risk 
factors for late sepsis.11 As the immunity of  HIV positive 
patients declines, the risk of  late sepsis around implants 
increases, some resulting from activation of  latent 
bacteria, others from late haematogeneous seeding. Such 
observations have been made following trauma implants and 
arthroplasties12.
Criteria for Choosing surgery
Arthroplasty is primarily a pain-relieving therapy. In so doing 
it often also improves function.
The patient having a diagnosis of  HIV disease should not 
necessarily deter arthroplasty.  Early outcomes after trauma 
implant surgery were good if  the skin is intact and the 
conditions ideal13.  The limited literature on arthroplasty is 
also encouraging in the short-term.  There are no reports 
of  medium or long-term outcomes of  arthroplasty in non-
haemophiliacs with HIV disease.
5-10% of  HIV-infected individuals are described as “rapid 
progressors”, with progression from infection to AIDS 
taking as little as 2 years as a result of  declining CD4 counts, 
and non-cytolytic CD8 activity14. The characteristics of  
“rapid-progressors” have been described by Brijlall as those 
with persistent inguinal lymphadenopathy, dermatological 
abnormalities, hyperpigmentation and minor symptoms 
such as fatigue and myalgia.  Primary infection in rapid 
progressors will tend to be far more severe and symptomatic 
than in other patients and so such individuals require special 
consideration before opting for surgery. An absolute CD4 
count is therefore not the best indicator of  whether to offer 
surgery.  Thus Brijlall suggests ascertaining whether an 
individual is a rapid progressor or long-term non-progressor, 
as well as the stage of  the disease, is more important1. 
The outcome of  total arthroplasty is also likely to be 
dependent on factors such as nutritional status, disease stage, 
and co-morbidity.
HAART’s and impact upon arthroplasty in HIV 
positive patients
Whilst non-haemophiliac HIV positive patients are not often 
sufferers of  degenerative arthropathy, as they are too young, 
they do, however, suffer from inflammatory arthropathy 
and avascular necrosis. Harrison and Brijlall13 have both 
suggested a possible association of  avascular necrosis with 
highly-active anti-retroviral therapy (or HAART). There 
are patients without any other risk factors for avascular 
necrosis who develop AVN, and a current hypothesis is that 
protease inhibitors may cause hyperlipidaemia 15. However, 
Brijlall suggests that in some patients, the AVN may have 
developed before the anti-retroviral therapy, and that HIV 
or other factors may increase the risk of  AVN, despite 
antiphospholipid antibodies (APLA) being found in HIV 
positive patients: the importance of  this is unclear16. Within 
Brijlall’s cohort with osteonecrosis, many of  the patients 
had multiple risk factors for AVN including corticosteroid 
use (1 eczema patient), alcohol abuse (6), smoking (10), 
hypercholesterolaemia (2), and antiviral therapy (3), and thus 
defining particular reasons for AVN was difficult.
Antiretroviral therapy is, of  course, highly beneficial to the 
HIV positive patient and whilst there may be some associated 
risk in terms of  avascular necrosis, these therapies do elevate 
CD4 counts relative to patients not receiving therapy, and 
the question of  whether the therapy reduces the risk of  
early and late sepsis in HIV positive patients by raising the 
CD4 count has yet to be answered10. In order to determine 
whether deep infection occurs as immunity declines, it is 
necessary to carry out further long-term follow-up studies. 
It is hoped that the Malawi National Joint Registry will be 
ideally placed to assess this.
Conclusion
Arthroplasty can be rewarding for the HIV positive patient, 
provided the correct criteria are used to ascertain whether 
a patient is suitable for surgery: in summary a patient who 
has severe pain, and has not progressed to stage IV (AIDS-
defining disease, according to WHO) is likely to experience 
benefits from arthroplasty, but a risk: reward ratio analysis is 
certainly necessary before any operation is performed. Both 
Lubega et al and Brijlall in separate studies have confirmed 
that arthroplasty in HIV positive patients is a safe procedure 
and can proceed with minimal early complications , so long 
as the skin is intact and conditions ideal9, and provided 
patients are not rapid-progressors and/or have progressed 
to clinical stage IV (WHO), or the AIDS-defining stage. As 
regards medium and long-term outcomes, only time will tell.
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